The present invention relates to compounds of formula I: ##STR00001## and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

 
Web www.patentalert.com

< Obesity controlling method

> 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives

> Substituted indolizines and derivatives as CNS agents

~ 00554